Freddie Mac Sells $586 Million in NPLs
Awards 2 SPO Pools to One WinnerMCLEAN, Va., Sept. 26, 2023 (GLOBE NEWSWIRE) -- Freddie Mac (OTCQB: FMCC) today announced...
Read moreDetails
Carmot Therapeutics Announces Two Oral Presentations Featuring Clinical Data from its Pipeline of Treatments for Obesity and Diabetes at the 59th European Association for the Study of Diabetes (EASD) Annual Meeting
– Phase 1 data for CT-388, a once-weekly injectable, dual GLP-1/GIP receptor agonist in development for the treatment of obesity...
Read moreDetailsLurie Children’s expands partnership with NRC Health to gain valuable consumer insights
LINCOLN, Neb., Sept. 26, 2023 (GLOBE NEWSWIRE) -- NRC Health is pleased to announce that Lurie Children’s Hospital of Chicago...
Read moreDetailsAvant Technologies Reshaping Future of Supercomputing and AI with Disruptive Private Cloud Infrastructure
LAS VEGAS, NV, Sept. 26, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Avant Technologies, Inc. (OTCQB: AVAI) (“Avant” or the “Company”), an artificial...
Read moreDetailsTreez Announces Multiple Advancements In FinTech Offerings for Cannabis Retailers
TreezPay One Application - A streamlined online application process that allows retailers to apply and get expedited approval for multiple...
Read moreDetailsAITX to Host Investor Town Hall and RAD Technology Reveal
November 3rd Event to Showcase Solutions from AITX Subsidiaries RAD, RAD-M and RAD-G Detroit, Michigan, Sept. 26, 2023 (GLOBE NEWSWIRE)...
Read moreDetailsCentury Lithium Corp. to Present at the Metals and Mining Virtual Investor Conference October 3rd
Company invites individual and institutional investors, as well as advisors and analysts, to attend in person or online at VirtualInvestorConferences.comVANCOUVER,...
Read moreDetailsOSS Secures Award for Submarine Sonar Data Processing System
OSS First AI Transportable Design Win for a Foreign Navy Secured Through New Global Prime Contractor PartnerESCONDIDO, Calif., Sept. 26,...
Read moreDetailsLIXTE Appoints Bas van der Baan as President and Chief Executive Officer
Lixte Biotechnology Holdings, Inc. Bas van der Baan, Newly Appointed President, CEO, Vice Chairman, LIXTE Biotechnology Holdings Biotechnology Veteran Bas...
Read moreDetailsVeru Reaches Agreement with FDA on New Phase 3 Clinical Trial for Sabizabulin for Broader Indication: Hospitalized Adult Patients with Any Type of Viral Acute Respiratory Distress Syndrome (ARDS)
--Reached agreement with FDA on single Phase 3 clinical trial design to expand treatment population to include all hospitalized adult...
Read moreDetailsADVERTISEMENTS
